Suppression of Choroidal Neovascularization by Vaccination With Epitope Peptide Derived From Human VEGF Receptor 2 in an Animal Model

Investigative Ophthalmology and Visual Science - United States
doi 10.1167/iovs.07-0523
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Related search

Inhibition of Experimental Choroidal Neovascularization by a Novel Peptide Derived From Calreticulin Anti-Angiogenic Domain

2018English

Suppression of Choroidal Neovascularization by Intravitreal Injection of Liposomal SU5416

Archives of Ophthalmology
2011English

Suppression of Laser-Induced Choroidal Neovascularization by a CCR3 Antagonist

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2013English

Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent Against (Pro)renin Receptor

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2019English

Inhibition of VEGF Secretion and Experimental Choroidal Neovascularization by Picropodophyllin (PPP), an Inhibitor of the Insulin-Like Growth Factor-1 Receptor

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2008English

Targeting Platelet-Derived Growth Factor Receptor Β + Scaffold Formation Inhibits Choroidal Neovascularization

American Journal of Pathology
Forensic MedicinePathology
2016English

Receptor Epitope Usage by an Interleukin-5 Mimetic Peptide

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

Suppression of Corneal Neovascularization by PEDF Release From Human Amniotic Membranes

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2004English

Optimization of an Image-Guided Laser-Induced Choroidal Neovascularization Model in Mice

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy